Skip to content

Medical emergency? What to do

Drugs don't work for many India AIDS patients

3-RXPublished August 11, 20065 min read

Key points

  • The drugs Shyamal Kumar Dey takes to fight AIDS don't work anymore.
  • Since then, the virus has found a new lease on life in his body, sapping both his immune system and his hopes for the future.
  • Unfortunately, these drugs are so expensive that even the Indian government, which pays for Dey's now useless first-line drugs, says it cannot afford to include second-line drugs in its national program.
  • Dey's job as a counselor to other HIV sufferers pays about 4,000 rupees a month, barely enough to cover the rent, feed his family and school his 6-year-old son.

The drugs Shyamal Kumar Dey takes to fight AIDS don't work anymore.

The 38-year-old father of one has been swallowing antiretroviral pills for the last five years, enough time for the HIV virus to mutate into a drug-resistant form.

Since then, the virus has found a new lease on life in his body, sapping both his immune system and his hopes for the future.

Ditching his current pills and switching to so-called "second-line" drugs would almost certainly bring Dey's disease back under control.

Unfortunately, these drugs are so expensive that even the Indian government, which pays for Dey's now useless first-line drugs, says it cannot afford to include second-line drugs in its national program.

A month's supply costs between 4,000 and 8,500 rupees ($85-$180), compared to the 450 rupees cost for first-line drugs.

Dey's job as a counselor to other HIV sufferers pays about 4,000 rupees a month, barely enough to cover the rent, feed his family and school his 6-year-old son.

Although India is one of the world's largest manufacturers of generic antiretrovirals, Dey has no idea how to get his hands on second-line drugs that could prolong and improve his life.

"I don't know what's going to happen," Dey said. "Whatever God will do I must accept."

AIDS researchers will debate the plight of people like Dey and other issues at the 16th International AIDS Conference, the world's biggest conference about the disease, in Toronto next week.

SECOND-LINE MUST WAIT

One in every seven HIV-positive people lives in India, home to an estimated 5.7 million people with the virus, according to UNAIDS, the United Nations' HIV and AIDS prevention agency.

A good half a million of those are likely to have immune systems so weak that they need antiretroviral drugs.

Of these, the government reaches only 35,000 people -- or 7 percent -- with free first-line drugs through its National AIDS Control Organisation (NACO).

Many people, particularly in rural India, simply do not know they have the virus and die without treatment.

India is finalizing this month the next five years of its AIDS control strategy and has decided it is more important to get more needy people taking first-line drugs than to introduce second-line medication, according to the World Health Organisation's Dr Po-Lin Chan, an adviser to the program.

The country, which began its free antiretroviral program in 2004, aims to get 300,000 people on first-line drugs by 2012.

"We have to ask ourselves what the priorities are," said Chan. "Probably 90 percent of patients will need first-line drugs for quite some time, so let's keep them on them as long as possible."

But critics say problems in the first-line drug delivery systems are causing resistance to become more widespread.

PROBLEMS AHEAD

Immunity to first-line drugs develops particularly quickly -- perhaps within a year or two -- if AIDS patients repeatedly fail to gulp down their two or three pills a day.

Even among the most diligent takers of pills, NACO expects 2 to 3 percent of these patients to develop immunity annually -- at least 1,000 HIV patients every year at current treatment volumes.

But many other patients are developing resistance because they have been poorly advised or because clinics have run out of drugs -- problems NACO is working hard to fix.

A forthcoming study by the YRG Centre for AIDS Research concludes that between 15 and 20 percent of antiretroviral patients in the south Indian city of Chennai have a strain of HIV immune to first-line drugs.

Second-line drugs are more expensive than first-line medications because they are made using a more complex synthesis process out of costlier raw materials and are given in higher doses.

Economists say the gap would narrow if governments around the world moved jointly to include the drugs in their programs.

"I think prices can be considerably lower than they are today," said Indrani Gupta, head of the health policy research unit at New Delhi's Institute of Economic Growth.

"But there isn't yet a critical mass of demand for second-line drugs so there's no incentive for manufacturers to bring down prices," he added.

A DIFFERENT APPROACH

For the time being, Brazil remains the only "resource-strapped" country to supply free second-line drugs to its citizens, says the WHO's Chan.

It spends considerably more on its HIV/AIDS program than India despite having roughly a tenth of the caseload, with most of its budget spent on treatment.

By contrast, India spends the bulk of its money -- a total of $200 million for 2006 to 2007 -- on AIDS prevention programs rather than treatment. But not everyone believes it has struck the right balance.

So long as few people have access to second-line drugs, there is a greater risk of first-line-resistant strains of HIV becoming more widespread.

But even more fundamentally, India needs to identify and treat HIV-positive people to prevent the virus spreading.

Loon Gangte of the Delhi Network of Positive People advocacy group, said a good treatment program including a second-line treatment option can help encourage suspected HIV sufferers to get themselves diagnosed and take precautions.

"Prevention starts with positive people," says Gangte, who is himself HIV positive.

"Two people without HIV can have sex a thousand times in one night and they're not going to get HIV. But if I go tonight and have sex with one man there is a risk of passing on the infection."

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underAIDS/HIV

Keep reading

AIDS/HIV

Economic crisis could worsen HIV/AIDS epidemic: UN

Economic crisis and climate change concerns could affect the fight against the AIDS virus and lead to a "universal nightmare", the head of the United Nations' agency for HIV/AIDS said on Sunday. The global economic…

2 min read

AIDS/HIV

Possible cure for HIV patients?

On December 7th, an article was published in PLoS One that explained that researchers from UCLA AIDS Institute have found a way to use human stem cells to fight HIV-infected cells. The human stem cells can be…

1 min read

AIDS/HIV

HIV-infected Chinese children struggle with stigma

The second storey of this nondescript building in Fuyang city in China's central province of Anhui houses HIV-positive orphans, but unlike many other similar establishments, there are no signboards outside. Heavy…

4 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.